In the eyes of the beholders: Subjective experiences of positive symptoms among patients with symptoms of psychosis seeking psychotherapy

[1]  J. Baker,et al.  The relationship between conventional clinical assessments and momentary assessments of symptoms and functioning in schizophrenia spectrum disorders: A systematic review , 2021, Schizophrenia Research.

[2]  K. Berry,et al.  The relationship between appraisals of voices (auditory verbal hallucinations) and distress in voice-hearers with schizophrenia-spectrum diagnoses: A meta-analytic review , 2021, Schizophrenia Research.

[3]  H. Bosworth,et al.  Measurement Properties of Existing Patient-Reported Outcome Measures on Medication Adherence: Systematic Review , 2020, Journal of medical Internet research.

[4]  G. Ungvari,et al.  Prevalence of comorbid depression in schizophrenia: A meta-analysis of observational studies. , 2020, Journal of affective disorders.

[5]  J. Sanjuán,et al.  Positive and Useful Voices in Patients With Schizophrenia: Prevalence, Course, Characteristics, and Correlates. , 2020, The Journal of nervous and mental disease.

[6]  Y. Iwata,et al.  Insight and medication adherence in schizophrenia: An analysis of the CATIE trial , 2020, Neuropharmacology.

[7]  S. Moritz,et al.  Metacognitive and cognitive-behavioral interventions for psychosis: new developments
 , 2019, Dialogues in clinical neuroscience.

[8]  Gang Wang,et al.  Quality of Life in Schizophrenia: A Meta-Analysis of Comparative Studies , 2019, Psychiatric Quarterly.

[9]  C. Murray,et al.  Positive aspects of voice-hearing: a qualitative metasynthesis , 2019, Mental Health, Religion & Culture.

[10]  W. Mansell,et al.  Sources of Distress in First-Episode Psychosis: A Systematic Review and Qualitative Metasynthesis , 2018, Qualitative health research.

[11]  F. Caspar,et al.  Maintaining Delusional Beliefs to Satisfy and Protect Psychological Needs , 2018, Zeitschrift für Psychologie.

[12]  M. Ruggeri,et al.  Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression , 2018, JAMA psychiatry.

[13]  Steffen Moritz,et al.  The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis , 2017, European Archives of Psychiatry and Clinical Neuroscience.

[14]  M. Hiligsmann,et al.  A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. , 2016, British journal of clinical pharmacology.

[15]  M. Broome,et al.  Auditory verbal hallucinations in first-episode psychosis: a phenomenological investigation , 2016, BJPsych open.

[16]  F. Caspar,et al.  Motive-oriented therapeutic relationship building for patients diagnosed with schizophrenia , 2015, Front. Psychol..

[17]  S. Moritz,et al.  Is the content of persecutory delusions relevant to self-esteem? , 2015 .

[18]  S. Moritz,et al.  The other side of “madness”: frequencies of positive and ambivalent attitudes towards prominent positive symptoms in psychosis , 2015 .

[19]  S. Moritz,et al.  Nonadherence to antipsychotics: The role of positive attitudes towards positive symptoms , 2014, European Neuropsychopharmacology.

[20]  R. Tandon,et al.  Antipsychotic treatment of schizophrenia: an update. , 2014, Asian journal of psychiatry.

[21]  M. Lambert,et al.  The assessment of quality of life in clinical practice in patients with schizophrenia , 2014, Dialogues in clinical neuroscience.

[22]  M. De Hert,et al.  Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review , 2013, Therapeutic advances in psychopharmacology.

[23]  S. Moritz,et al.  Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis. , 2013, Schizophrenia bulletin.

[24]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[25]  D. Ben-Zeev,et al.  Comparing retrospective reports to real-time/real-place mobile assessments in individuals with schizophrenia and a nonclinical comparison group. , 2012, Schizophrenia bulletin.

[26]  G. Dunn,et al.  Differences in Cognitive and Emotional Processes Between Persecutory and Grandiose Delusions , 2012, Schizophrenia bulletin.

[27]  D. Linszen,et al.  Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade , 2012, European Psychiatry.

[28]  M. Hayward,et al.  Developing positive relationships with voices: A preliminary Grounded Theory , 2011, The International journal of social psychiatry.

[29]  D. Naber,et al.  Subjective experience and meaning of psychoses: the German Subjective Sense in Psychosis Questionnaire (SUSE) , 2011, Psychological Medicine.

[30]  S. Moritz,et al.  Course and determinants of self‐esteem in people diagnosed with schizophrenia during psychiatric treatment , 2010 .

[31]  D. Naber,et al.  Cure or Curse? Ambivalent Attitudes Towards Neuroleptic Medication in Schizophrenia and Non-Schizophrenia Patients , 2009, Mental illness.

[32]  J. Jenner,et al.  Positive and useful auditory vocal hallucinations: prevalence, characteristics, attributions, and implications for treatment , 2008, Acta psychiatrica Scandinavica.

[33]  G. Dunn,et al.  Emotion and psychosis: Links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations , 2006, Schizophrenia Research.

[34]  Marvin Swartz,et al.  Measuring outcome priorities and preferences in people with schizophrenia , 2005, British Journal of Psychiatry.

[35]  W. Mansell.  Control theory and psychopathology: an integrative approach. , 2005, Psychology and psychotherapy.

[36]  J. Os,et al.  Pleasurable auditory hallucinations , 2004, Acta psychiatrica Scandinavica.

[37]  M. Lambert,et al.  Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics , 2001, European Psychiatry.

[38]  N. Tarrier,et al.  Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS) , 1999, Psychological Medicine.

[39]  A. Wells,et al.  Are experiences of psychosis associated with unhelpful metacognitive coping strategies? A systematic review of the evidence. , 2018, Clinical psychology & psychotherapy.

[40]  Lizheng Shi,et al.  Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices , 2012, PharmacoEconomics.

[41]  A. Mackinnon,et al.  Correlates of the affective impact of auditory hallucinations in psychotic disorders. , 2004, Schizophrenia bulletin.

[42]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[43]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.